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Abstract
Background: Diagnostic delays are common in patients with interstitial lung disease (ILD). A substantial percentage
of patients experience a diagnostic delay in the primary care setting, but the factors underpinning this observation
remain unclear. In this multi-center investigation, we assessed ILD reporting on diagnostic test interpretation and its
association with subsequent pulmonology referral by a primary care physician (PCP).
Methods: A retrospective cohort analysis of patients referred to the ILD programs at UC-Davis and University of
Chicago by a PCP within each institution was performed. Computed tomography (CT) of the chest and abdomen
and pulmonary function test (PFT) were reviewed to identify the date ILD features were first present and determine
the time from diagnostic test to pulmonology referral. The association between ILD reporting on diagnostic test
interpretation and pulmonology referral was assessed, as was the association between years of diagnostic delay and
changes in fibrotic features on longitudinal chest CT.
Results: One hundred and forty-six patients were included in the final analysis. Prior to pulmonology referral, 66%
(n = 97) of patients underwent chest CT, 15% (n = 21) underwent PFT and 15% (n = 21) underwent abdominal CT.
ILD features were reported on 84, 62 and 33% of chest CT, PFT and abdominal CT interpretations, respectively. ILD
reporting was associated with shorter time to pulmonology referral when undergoing chest CT (1.3 vs 15.1 months,
respectively; p = 0.02), but not PFT or abdominal CT. ILD reporting was associated with increased likelihood of
pulmonology referral within 6 months of diagnostic test when undergoing chest CT (rate ratio 2.17, 95% CI 1.03–
4.56; p = 0.04), but not PFT or abdominal CT. Each year of diagnostic delay was associated with a 1.8% increase in
percent fibrosis on chest CT. Patients with documented dyspnea had shorter time to chest CT acquisition and
pulmonology referral than patients with documented cough and lung crackles.
Conclusions: Determinants of ILD diagnostic delays in the primary care setting include underreporting of ILD
features on diagnostic testing and prolonged time to pulmonology referral even when ILD is reported.
Interventions to modulate these factors may reduce ILD diagnostic delays in the primary care setting.
Keywords: Interstitial lung disease, Diagnostic delay, Idiopathic pulmonary fibrosis, Pulmonary function test,
Computed tomography
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Introduction
Interstitial lung disease (ILD) is made up of a heteroge-
neous group of diffuse parenchymal lung disorders that
often result in pulmonary fibrosis. ILD results in a high
burden of disease, leading to increased healthcare
utilization [1, 2] and reduced survival [3]. Despite these ob-
servations, diagnostic delays remain common. A majority
of patients report waiting more than 1 year from the time
of symptom onset to ILD diagnosis and often undergo mul-
tiple physician evaluations before arriving at the correct
diagnosis [4]. Even with recognition of this problem, little
headway has been made over the last decade [5, 6].
A recent investigation by Hoyer and colleagues
showed that ILD diagnostic delays occur in several set-
tings, with the primary care setting playing a prominent
role [7]. Factors leading to ILD diagnostic delays remain
unclear, but may stem from unrecognized or underap-
preciated features of ILD on diagnostic testing. ILD is
best characterized by computed tomography (CT) of the
chest and can range from subtle, sub-clinical reticular
opacities to parenchymal destruction characterized by
traction bronchiectasis and honeycombing [8–10]. ILD
can also be detected by abdominal CT, as lung bases are
commonly captured by this modality. While CT con-
firms the presence of ILD, physiologic features of ILD
can be detected on pulmonary function testing (PFT),
including reductions in total lung capacity (TLC), forced
vital capacity (FVC) and diffusion capacity of the lung
for carbon monoxide (DLCO) [11].
Studies to date characterizing diagnostic delays in pa-
tients with ILD have largely relied on patient questionnaires
and insurance claims data [4–7]. While informative, these
studies do not assess physician-level factors that may influ-
ence such delays. We showed previously that underreport-
ing of interstitial lung abnormalities on lung cancer
screening CT was associated with delays in pulmonology
referral [12], which suggests a similar phenomenon may
occur with diagnostic tests performed prior to ILD diagno-
sis. In this multi-center investigation, we reviewed all prior
chest CTs, abdominal CTs and PFTs performed in patients
referred to the ILD programs at UC-Davis and University
of Chicago to determine the time from first diagnostic test
showing features of ILD to pulmonology referral. We hy-
pothesized that ILD reporting on diagnostic test interpret-
ation would lead to reduced time to pulmonology referral.
We then assessed how diagnostic delays influenced pro-
gression of pulmonary fibrosis on longitudinal chest CT
and characterized time to chest CT and pulmonology refer-
ral following documentation of ILD clinical features, includ-
ing cough, dyspnea and lung crackles.
Methods
This retrospective cohort investigation was performed at
the University of California at Davis (UC-Davis) and the
University of Chicago (UChicago). The electronic med-
ical record was reviewed for all patients with an institu-
tional PCP who consented to participate in the ILD
registry at each center (UC-Davis IRB protocol #928979
and UChicago IRB protocol #13–1180). Patients with
prevalent ILD diagnosed by an outside pulmonologist
prior to ILD program referral were excluded, as were pa-
tients with missing clinical data or CT images.
Relevant data extracted from the electronic medical
record included demographics (age, sex, race, smoking
history), ILD signs and symptoms, ILD diagnosis, date of
pulmonology referral, date and interpretation of all chest
CT, abdominal CT and PFT. ILD features were consid-
ered reported on CT when there was mention of “reticu-
lation,” “reticular opacities” “honeycombing” “traction
bronchiectasis” “traction bronchiolectasis” “ground glass
opacity” “interstitial changes” “fibrosis” and “fibrotic
changes” on the radiology report. ILD was considered
reported on PFT when ILD was mentioned in the PFT
interpretation, including when listed as part of a differ-
ential diagnosis.
All chest and abdominal CTs performed prior to pul-
monology referral were reviewed by a thoracic radiolo-
gist (MK at UC-Davis and JHC at UChicago) to
ascertain the date of first CT with evidence of ILD. For
chest CTs, ILD was defined as bilateral, non-dependent
reticular opacities affecting > 5% of the lung. For abdom-
inal CT, ILD was defined as bilateral, non-dependent re-
ticular opacities at the lung bases. All PFTs performed
prior to pulmonology referral were reviewed by JMO
and AA to ascertain the date of first PFT with ILD fea-
tures, defined as TLC, FVC or DLCO was < 80% pre-
dicted. Paired chest CTs performed ≥6 months prior to
pulmonology referral and within 6months of pulmonol-
ogy evaluation at UC-Davis were then scored to deter-
mine the longitudinal change in fibrosis extent, defined
as the sum of whole lung percent reticular opacities and
honeycombing.
To explore the association between ILD clinical fea-
ture onset and subsequent ILD work-up, the time from
documentation of cough, dyspnea and lung crackles to
chest CT and pulmonology referral was assessed. ILD
clinical features were considered present when PCP
documentation of was sustained prior to chest CT and
pulmonology referral. These data could only be assessed
in the UC-Davis cohort, as a transition from paper to
electronic documentation during the study period pre-
cluded reliable acquisition of PCP records in the UChi-
cago cohort.
Statistical analysis
Continuous variables are presented as means ± standard
deviation or as medians with interquartile range based
on variable distribution. Time from diagnostic test to
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pulmonology referral is compared between ILD report-
ing groups using a generalized Wilcoxon test weighted
for early events and displayed using the Kaplan Meier
estimator. The association between diagnostic testing in-
terpretation and pulmonology referral within 6months
of testing was assessed using Poisson regression with ro-
bust error variance [13]. Longitudinal change in fibrotic
features on chest CT associated with diagnostic delay
was assessed using a maximum likelihood linear mixed
effects model with time between CTs aligned to 1-year
intervals. Age, sex, race, ILD subtype and smoking his-
tory were included as fixed effects variables to adjust for
potential confounders of fibrotic change over time. An
autoregressive correlation structure and random slope
term were chosen for longitudinal modeling based on
exploratory analysis using restricted maximum likeli-
hood testing. Longitudinal change in CT measures are
displayed graphically using locally weighted scatterplot
smoothing. All analyses were performed using Stata (Re-
lease 16; StataCorp, College Station, TX, USA). Statis-
tical significance was set at p < 0.05.
Results
Of 309 patients screened at UC-Davis, 207 were ex-
cluded, including 178 without an institutional PCP. Of
894 screened at UChicago, 850 were excluded, including
813 without an institutional PCP. One hundred and two
patients from UC-Davis and 44 from UChicago were in-
cluded in the final analysis (Fig. 1). Baseline characteris-
tics for each cohort are shown in Table 1. Those with
ILD from UChicago were younger and had a higher per-
centage of females and African Americans than those
from UC-Davis. Smoking history and reason for pulmo-
nology referral were similar between groups. ILD
diagnosis varied between centers, with unclassifiable pul-
monary fibrosis being most common at UCD-Davis and
connective tissue disease-associated ILD being most
common at UChicago. Idiopathic pulmonary fibrosis
(IPF) accounted for approximately 25% of both cohorts.
Patients at UC-Davis had better overall lung function
than patients in the UChicago cohort.
Chest computed tomography
A chest CT with features of ILD was obtained in 66%
(n = 97) of patients prior to pulmonology referral, with
ILD reported on chest CT interpretation in 84% (n = 81/
97) of cases (Table 2). The median time to pulmonology
referral was 1.3 months (IQR 0.3–11.5 months) in those
for whom ILD was reported and 15.1 months (IQR 3.0–
31.0 months) in those for whom ILD was not reported
(p = 0.02) (Fig. 2a). A pulmonology referral was placed
within 6 months of chest CT in 68% (n = 55/81) of pa-
tients for whom ILD was reported and 31% (n = 5/16)
for whom ILD was not reported (Table 3). Reporting of
ILD on chest CT interpretation was associated with a
two-fold increase in likelihood of pulmonology referral
within 6 months of chest CT (rate ratio (RR) 2.17; 95%
CI 1.03–4.56; p = 0.04). Despite these findings, the time
from chest CT to pulmonology referral was > 1 year for
roughly 25% of patients for whom ILD was reported on
chest CT. A similar time to pulmonology referral was
observed between IPF and non-IPF cohorts (20.4 vs 13.9
months, respectively; p = 0.41).
Pulmonary function testing
A PFT with features of ILD was obtained in 14% (n =
21) of patients prior to chest CT and pulmonology refer-
ral, with ILD reported on PFT interpretation in 62%
Fig. 1 Consort/STROBE diagram
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Table 1 Baseline Characteristics upon ILD Program Evaluation
Variable UCD Cohort (n = 102) UChicago Cohort (n = 44)
Age, mean (SD) 72.5 (9.5) 59.8 (14.1)
Male, n (%) 64 (62.8) 17 (38.6)
Race, n (%)
White 87 (85.3) 9 (20.5)
African American 3 (2.9) 34 (77.3)
Hispanic 5 (4.9) 1 (2.3)
Asian 7 (6.9) 0 (0)
Smoking History
Never, n (%) 38 (37.3) 17 (38.6)
Former or current, n (%) 64 (62.8) 27 (61.4)
Pack-years if former/current, median (IQR) 20 (10–42.5) 22 (15–40)
Pulmonary Referral Reason
Abnormal imaging/ILD, n (%) 63 (61.8) 35 (79.6)
Cough and/or dyspnea, n (%) 19 (18.6) 7 (15.9)
Abnormal PFT 6 (5.9) 1 (2.3)
Other, n (%) 14 (13.7) 1 (2.3)
ILD Diagnosis, n (%)
Idiopathic pulmonary fibrosis 28 (27.5) 12 (27.3)
CTD-associated ILD 20 (19.6) 22 (50)
Chronic HP 10 (9.8) 2 (18.2)
Unclassifiable Fibrosis 34 (33.3) 8 (18.2)
Other ILD 10 (9.8) 0 (0)
Pulmonary Function
Total lung capacity (% predicted), mean (SD) 79 (17) 72 (18)
Forced vital capacity (% predicted), mean (SD) 83 (19) 66 (18)
Diffusion capacity (% predicted), mean (SD) 59 (17) 54 (20)
Table 2 Time to chest CT and pulmonology referral after diagnostic testing in patients with ILD
Variable ILD reported ILD not reported p-value
Chest CT
Chest CT with ILD featuresa obtained prior to pulmonology referral, n (%) 81/97 (83.5) 16/97 (16.5)
Months from chest CT to pulmonology referral, median (IQR) 1.3 (0.3–11.5) 15.1 (3.0–31.0) 0.02
Pulmonary Function Testing
PFT with ILD featuresb obtained by PCP prior to chest CT and pulmonology referral, n (%) 13/21 (61.9) 8/21 (38.1)
Months from PFT to chest CT when ILD reported by pulmonologist, median (IQR) 3.7 (0.8–14.8) 13.1 (1.6–27.8) 0.2
Months from PFT to pulmonology referral when ILD reported, median (IQR) 4.4 (1.2–34.1) 12.1 (0.5–37.2) 0.74
Abdominal CT
Abdominal CT with ILD featuresc obtained prior to chest CT and pulmonology referral, n (%) 7/21 (33.3) 14/21 (66.7)
Months from abdominal CT to chest CT when ILD not reported by radiologist, median (IQR) 12.3 (2.3–28.2) 21.4 (17.9–70.7) 0.1
Months from abdominal CT to pulmonology referral when ILD reported by radiologist, median (IQR) 24.4 (13.2–44.6) 63.9 (20.0–106.3) 0.11
aBilateral, non-dependent reticular opacities affecting > 5% of lung area
bTLC or FVC or DLCO < 80% predicted
cBilateral, non-dependent reticular opacities at lung bases
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(n = 13/21) of cases (Table 2). The median time from
PFT to chest CT was 3.7 months (IQR 0.8–14.8 months)
in those for whom ILD was reported on PFT and 13.1
months (IQR 1.6–27.8 months) in those for whom ILD
was not reported (p = 0.2) on PFT. The median time to
pulmonology referral was 4.4 months (IQR 1.2–34.1
months) in those for whom ILD was reported on PFT
and 12.1 months (IQR 0.5–37.2 months) in those for
whom ILD was not reported on PFT (p = 0.74) (Fig. 2b).
A pulmonology referral was placed within 6 months of
PFT in 62% (n = 8/13) of patients for whom ILD was re-
ported and 50% (n = 4/8) of those for whom ILD was
not reported (Table 3). Reporting of ILD on chest PFT
interpretation was not associated with differential likeli-
hood of pulmonology referral within 6 months of PFT
(RR 1.23; 95% CI 0.54–2.78; p = 0.62).
Abdominal computed tomography
An abdominal CT with features of ILD was obtained in
14% (n = 21) of patients prior to chest CT and pulmonol-
ogy referral, with ILD reported on PFT interpretation in
33% (n = 7/21) of cases (Table 2). The median time from
abdominal CT to chest CT was 12.3months (IQR 2.3–
28.2months) in those for whom ILD was reported on ab-
dominal CT interpretation and 21.4months (IQR 17.9–
70.7months) in those for whom ILD was not reported
(p = 0.1). The median time to pulmonology referral was
24.4months (IQR 13.2–44.6months) in those for whom
ILD was reported of abdominal CT interpretation and
63.9months (IQR 20.0–106.3 months) in those for whom
ILD was not reported (p = 0.11) (Fig. 2c). A pulmonology
referral was placed within 6months of abdominal CT in
14% (n = 1/7) of patients for whom ILD was reported on
abdominal CT and 14% (n = 2/14) for whom ILD was not
reported. Reporting of ILD on chest PFT interpretation
was not associated with differential likelihood of pulmo-
nology referral within 6months of abdominal CT (RR 1;
95% CI 0.11–9.23; p = 1.0) (Table 3).
Diagnostic delays and progression of pulmonary fibrosis
Fifty-one patients had paired chest CT performed prior
to and at the time of ILD program evaluation, including
32 from UC-Davis and 19 from UChicago. The median
time between chest CTs was 29months (IQR 10–46).
With a baseline percent fibrosis of 14.6%, each year
delay prior to ILD program evaluation was associated
with a 1.8% (95% CI 1.08–2.57, p < 0.001) increase in fi-
brosis extent (Fig. 3). This was most pronounced among
patients with IPF, with each year delay prior to ILD pro-
gram evaluation associated with a 2.94% (95% CI 0.86–
5.03%; p = 0.006) increase in fibrosis extent. Non-IPF
ILDs had similar yearly increases in fibrosis extent, with
CTD-ILD demonstrating an annual increase of 1.22%
(95% CI -0.17-2.62; p = .09) and combined other ILDs
demonstrating an annual increase of 1.33% (95% CI
0.76–1.90; p < 0.001).
Relationship between ILD clinical feature onset, chest CT
acquisition and pulmonology referral
At least one clinical feature of ILD was documented by a
PCP in 87% of cases (n = 89) (Table 4), including 64%
Fig. 2 Time to pulmonology referral stratified by ILD reporting in
those undergoing chest computed tomography (a), pulmonary
function testing (b) and abdominal computed tomography (c)
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(n = 66) with cough, 53% (n = 54) with dyspnea and 35%
(n = 36) with lung crackles. The median time from
cough documentation to pulmonology referral was 13.2
months (IQR 1.8–58.9 months), with 41% (n = 27/66) of
patients receiving a pulmonology referral within 6
months of cough onset. Among patients who underwent
chest CT prior to pulmonology referral, the median time
from documented cough to chest CT was 29.1 months
(IQR 0.7–63.0), with 29% (n = 13) of patients undergoing
chest CT within 6 months of documented cough onset.
The median time from dyspnea documentation to pul-
monology referral was 1.6 months (IQR 0.7–5.5 months),
with 69% (n = 37/54) of patients receiving a pulmonol-
ogy referral within 6 months of dyspnea onset. Among
patients who underwent chest CT prior to pulmonology
referral, the median time from documented dyspnea to
chest CT was 1.2 months (IQR 0.4–4.1), with 41% (n =
14/34) of patients undergoing chest CT within 6months
of documented dyspnea onset. The median time from
lung crackles documentation to pulmonology referral
was 16.3 months (IQR 2.3–37.1 months), with 36% (n =
13/36) of patients receiving a pulmonology referral
within 6 months of lung crackles onset. Among patients
who underwent chest CT prior to pulmonology referral,
the median time from documented lung crackles to
chest CT was 10.8 months (IQR 0.8–37.3), with 23%
(n = 7/30) of patients undergoing chest CT within 6
months of documented lung crackles onset.
Discussion
In this investigation we assessed physician-level factors in-
fluencing diagnostic delays in patients with ILD across two
academic institutions. We found that ILD reporting was
highly variable across key diagnostic tests, including 84%
reporting on chest CT, 62% on PFT and only 33% on ab-
dominal CT. While ILD reporting was associated with re-
duced time to pulmonology referral across each diagnostic
testing modality, only chest CT reached statistical signifi-
cance. We also showed that each year of diagnostic delay
was associated with a 1.8% increase in fibrosis extent on
longitudinal chest CT and that documented dyspnea was
associated with more prompt chest CT acquisition and pul-
monology referral than documented cough or lung
crackles. This study is among the first to assess physician-
level factors contributing to ILD diagnostic delays and
sheds important light on potential targets for intervention.
ILD reporting was most strongly associated with
prompt pulmonology referral in patients undergoing
Table 3 Association between 6-month pulmonology referral and diagnostic testing
ILD Features Reported on Diagnostic Testing Interpretation
(+) (−) (+) (−) (+) (−)
Chest CT Pulmonary Function Testing Abdominal CT
n with referral time < 6months/total (%) 55/81 (67.9) 5/16 (31.3) 8/13 (61.5) 4/8 (50) 1/7 (14.3) 2/14 (14.3)
Rate ratio 2.17 Ref 1.23 Ref 1 Ref
p-value 0.04 Ref 0.62 Ref 1 Ref
95% Confidence Interval 1.03–4.56 Ref 0.54–2.78 Ref 0.11–9.23 Ref
Fig. 3 Yearly change in percent fibrosis associated with ILD referral delay
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chest CT. We found that ILD was reported on 84% of
chest CTs and that this reporting increased by two-fold
the likelihood of pulmonology referral within 6 months
of chest CT. However, we also found that nearly 25% of
patients for whom ILD was reported on chest CT still
waited more than year before receiving a pulmonology
referral. These data support our previous findings, in
which underreporting of interstitial lung abnormalities
was common in patients undergoing chest CT for lung
cancer screening and was associated with delays in pul-
monology referral [12]. Adoption of a standardized chest
CT reporting template for ILD, as was recently proposed
by Berkowitz and colleagues [14], may improve ILD
reporting by providing a standardized framework for de-
scribing common ILD features. While systematic screen-
ing of all chest CT performed at an institution would
likely improve ILD reporting, a more practical approach
given the relatively high prevalence of ILD reporting
may be systematic screening of chest CT reports
followed by a recommendation for pulmonology referral
when ILD features are reported.
While a large percentage of patients underwent chest
CT prior to pulmonology referral in this study, only 14%
of patients underwent PFT prior to referral and of those
patients, only 62% of those had ILD reported on the
PFT interpretation despite the presence of ILD features.
ILD reporting was associated with a shorter time to
chest CT and pulmonology referral, but neither of these
associations reached statistical significance. We also
found that ILD reporting on PFT interpretation was not
associated with differential likelihood of pulmonology re-
ferral within 6 months of PFT. ILD often results in char-
acteristics changes on PFT, including reductions in TLC,
FVC and/or DLCO [11]. However, isolated or composite
reductions in these metrics can be observed in numer-
ous unrelated disease states [15–19], which may explain
why mention of ILD was less strongly associated with
pulmonology referral in these patients. Systematic
screening of PFTs followed by a recommendation for
chest CT or pulmonology referral when ILD features are
present may facilitate a reduction in diagnostic delays
observed in these patients. The PFT metrics that most
reliably discriminate ILD among all-comers remains un-
clear, but Suliman and colleagues showed that specific
composite measures had a sensitivity of > 70% for de-
tecting ILD in patients with scleroderma [15].
While improved reporting of ILD may facilitate a re-
duced time to pulmonology referral in patients undergo-
ing chest CT, it is not clear from our data that improved
ILD reporting would result in a similar outcome in pa-
tients undergoing abdominal CT. We found that ILD
was reported in only 33% of abdominal CT interpreta-
tions. While this reporting was associated with a reduced
time to pulmonology referral, this association was not
statistically significant and the median time to pulmo-
nology referral was greater than 2 years. These findings
suggest that efforts are needed to both improve ILD
reporting on abdominal CT and to facilitate pulmonol-
ogy referral once ILD is reported. A review of lung win-
dows by a thoracic radiologist for these studies could
help address the ILD reporting component, while sys-
tematic screening of abdominal CT reports in the setting
of improved reporting could help address the referral
component.
The non-specific nature of ILD symptoms likely con-
tributes to the diagnostic delays observed in this popula-
tion. Chronic cough and dyspnea are the predominate
symptoms in patients with ILD [6], but are commonly
observed with other lung diseases and non-pulmonary
etiologies. Our data suggest that most patients with doc-
umented dyspnea receive prompt chest CT and pulmo-
nology referral, but that substantial delays occur in
patients with documented chronic cough and lung
crackles. We found that the median time to pulmonol-
ogy referral of > 1 year following documentation of
cough and lung. While not all patients with chronic
cough warrant a chest CT, a recommendation for this
diagnostic modality for patients who fail to improve with
standard treatments such as bronchodilators, anti-reflux
therapy and sinus hygiene should be considered. Lung
crackles should prompt a more expeditious work-up.
While lung crackles can sometimes be auscultated in the
dependent lung portions of healthy individuals [20], they
should be considered pathologic when failing to resolve
over several breath cycles. The presence of pathologic
lung crackles are strongly predictive of pulmonary fibro-
sis [21], and have accordingly been proposed as a screen-
ing tool for ILD [22].
While our study focused on factors influencing diag-
nostic delays within two academic institutions, Hoyer
Table 4 Time from documented ILD clinical feature to chest CT
and pulmonology referral
Variable UCD Cohort (n = 102)
Any ILD clinical feature documented, n (%) 89 (87.3)
Chronic cough, n (%) 66 (64.7)
Dyspnea, n (%) 54 (52.9)
Lung crackles, n (%) 36 (35.3)
Months from ILD clinical feature to chest CT
Chronic cough, median (IQR) 29.1 (0.7–63)
Dyspnea, median (IQR) 1.2 (0.4–4.1)
Lung crackles, median (IQR) 10.8 (0.8–37.3)
Months from ILD clinical feature pulmonology referral
Chronic cough, median (IQR) 13.2 (1.8–58.9)
Dyspnea, median (IQR) 1.6 (0.7–5.5)
Lung crackles, median (IQR) 16.3 (2.3–37.1)
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and colleagues recently provided a more global assess-
ment of diagnostic delays in patients with ILD using na-
tional health data in Denmark [7]. Similar primary care-
related delays were observed, but significant delays re-
lated to patient factors and within the community pul-
monologist setting were also identified. Notably, small
but measurable delays were also observed prior to ILD
specialty center evaluation and while undergoing the
ILD work-up within specialty centers. While our study
provides some insight into factors influencing diagnostic
delays in the primary care setting, the work of Hoyer
and colleagues suggests that other avenues for interven-
tion exist.
Our study has several limitations. First, given the
retrospective nature of the study, our study allowed only
for assessment of association and not causation. Next,
while this was a multi-center investigation, the sample
size was small and likely resulted in an underpowered
study for detection of association between ILD reporting
and time to pulmonology referral in those undergoing
PFT and abdominal CT. Next, heterogeneity existed be-
tween cohorts with regard to baseline characteristics and
individual outcome measures, suggesting that center-
specific considerations may be needed when formulating
strategies to reduce ILD diagnostic delays. Finally, be-
cause of our study design, we could only assess factors
influencing diagnostic delays within our health systems,
both of which are academic medical centers with a large
external referral population relative to internal referrals.
Whether these results are generalizable to cohorts drawn
from community centers remains unclear; however, the
consistencies of our findings with those of others who
have included patients from community centers do sug-
gest some degree of generalizability [5–7].
Conclusion
The high prevalence of diagnostic delays in patients with
ILD was first reported over a decade ago and recent
studies suggest that little has changed since that time.
We and others have begun to identify specific factors
that influence diagnostic delays in patients with ILD,
providing potential strategies to positively impact this
unfortunate phenomenon. Additional research is needed
to identify cost effective strategies to reduce diagnostic
delays, including physician education and systematic
screening programs.
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